https://www.selleckchem.com/pr....oducts/oxiglutatione
48, 95% CI 4.51-6.65) was higher in men. Among borderline significantly different risk estimates was BMI ≥27, associated with higher risk for incRKOA in women (RR 2.00, 95% CI 1.74-2.31). The PAF for higher BMI was 25.6% in women and 19.3% in men. We found sex-specific differences in both presence and relative risks of several risk factors for incRKOA. Especially BMI, a modifiable risk factor, impacts women more strongly than men. These risk factors can be used in the development of personalized prevention strategies and in buildi